New findings in mice and people provide insight into the development of high blood pressure during pregnancy, a dangerous condition that occurs in about 10 percent of pregnancies. The study suggests that the condition can arise from misregulation of the hormone ANP (atrial natriuretic peptide) and an enzyme that regulates it. These factors are necessary for the proper formation of blood vessels in the maternal-fetal interface.
Making a ''Good'' Egg BOR-Papers in Press published 11 April 2012 DOI: 10.1095 During its long developmental trajectory, the oocyte undergoes many transitions necessary for life, including completion of meiosis, quelling of retrotransposon activity, and preparation of the cytoplasmic molecular milieu for fertilization and embryogenesis. Researchers have now identified a protein required for all three of these events.
The protein, dubbed MARF1 (meiosis arrest female 1), was identified in a genetic screen for female mice that were infertile. Oocytes from mice lacking MARF1 have aberrant cytoplasmic maturation and are unable to complete meiosis. They also have additional defects, including upregulation of lap and Line1 retrotransposon messenger RNAs, and an increase in DNA double-strand breaks.
MARF1 encodes a protein, expressed at high levels in oocytes, that has motifs suggesting it may regulate RNA. Consistent with this observation, the researchers found that hundreds of transcripts were upregulated in oocytes lacking MARF1. One transcript that was upregulated was the cell cycle regulator PPP2Cl. Its inappropriate expression may underlie the meiotic defect in MARF1 mutant oocytes; about 70 percent of mutant oocytes resumed meiosis when cultured with an inhibitor of PPP2C.
The researchers found that oocytes in the MARF1 mutant that had been induced to undergo meiosis did not progress to cleavage or embryonic development after in vitro insemination. That observation suggests that MARF1 does more than assure proper progression through meiosis, and acts more broadly to prepare the oocyte for fertilization and embryogenesis.
MARF1 likely has conserved functions among species, given that there is 86-percent identity between mouse and human MARF1. Shortly after fertilization, a protein in the protective coat of the mammalian egg is cleaved, barring entry to other sperm. Jurrien Dean and colleagues now identify the protease responsible for this cleavage, increasing understanding of how the egg blocks entry of multiple sperm.
Previous studies have shown that, shortly after fertilization, the egg releases the contents of organelles close to the egg membrane called cortical granules. The granules are thought to contain a protease that cleaves the zona pellucida protein ZP2, altering the egg's coat so that sperm cannot bind to it, thus acting as one of several mechanisms to assure that only one sperm enters the egg.
Dean and colleagues first identified a candidate protease based on its target cleavage site and previous observations that it is highly expressed in the egg. They found that the protein, ovastacin, localized to cortical granules in mouse eggs before, but not after, fertilization. The researchers also examined female mice lacking ovastacin and found that ZP2 was not cleaved in their eggs and that sperm continued to bind to the zona pellucida long after fertilization, even after the first cell division of the zygote. Moreover, the researchers found that recombinant ovastacin could cleave ZP2 in eggs in a test tube.
The gene that encodes ovastacin is well conserved across species and is found in humans, where it may play a similar role in blocking polyspermy. If that is the case, then ovastacin could potentially serve as a target for contraception development. Researchers have identified a transcriptional network that underlies proper development of the placenta. The three transcriptional factors involved are part of the E2f family, a highly conserved set of genes involved in regulating the cell cycle.
Previous work by Gustavo Leone and colleagues showed that factors E2f7 and E2f8 are required for embryo survival in mice. The researchers have now found that embryos lacking those factors die due to improper development of the fetal component of the placenta.
The investigation demonstrated that embryos lacking E2f7 and E2f8 can develop normally as long as their placentas express those transcription factors. However, eliminating the function of E2f7 and E2f8 in the cells of the trophoblast, which gives rise to the fetal component of the placenta, results in over-proliferation of the trophoblast, consistent with studies showing that E2f7 and E2f8 participate in regulation of the cell cycle. As a likely consequence of this proliferation, the placenta is misshapen and deformed, and it fails to effectively invade maternal tissue.
The researchers next showed that another transcription factor, E2f3a, counteracts the activity of E2f7 and E2f8. Eliminating the function of E2f7, E2f8, and E2f3a together results in normal placental and embryonic development.
Previous studies have shown that different E2f transcription factors may have specific roles in various tissues. The new findings are consistent with those observations and serve to pinpoint a set of regulators specific to the placenta that may regulate the cell cycle and other events. Ovastacin localizes to secretory granules in the cortex of the unfertilized egg. There, it is poised for release after fertilization. Red, ovastacin; green, secretory granules; yellow, co-localized structures. Credit: Burkart et al., J Cell Biol 2012.
